Reference : L’interruption médicamenteuse de grossesse : applications cliniques de la mifépriston...
Scientific journals : Article
Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics)
http://hdl.handle.net/2268/140173
L’interruption médicamenteuse de grossesse : applications cliniques de la mifépristone et des prostaglandins.
English
FIRQUET, Anne [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >]
BELIARD, Aude mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >]
Chabbert-Buffet, N []
PINTIAUX, Axelle [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >]
Foidart, Jean-Michel mailto [Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique >]
2011
Revue Médicale de Liège
Université de Liège. Revue Médicale de Liège
66
12
614-618
Yes (verified by ORBi)
International
0370-629X
Liège
Belgique
[en] Abortion ; Miscarriage ; Mifepristone ; Misoprostol
[en] summarY : mifepristone is one of the most common selective progesterone receptor modulator. its use in abortion in first and second trimester of pregnancy is well known. this type of molecule has also been studied in several diseases such as endometriosis, myomas, breast cancer and meningioma. only practical management of abortion using mifepristone will be
described here.
http://hdl.handle.net/2268/140173

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Firquet A Rev Med lieg 2011.pdfPublisher postprint200.93 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.